Fundraising Fox
Peter Thompson
InvestorGeneral Partner at OrbiMed · Board director at Terremotobio · Board director at Alpheus Medical · Board director at Janux Therapeutics
Bellevue, Washington
Writes $1M – $75M checks · typically $4M
Find your path to Peter
302 people in our graph can introduce you to Peter.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Chris Chai to introduce you to Peter
You →Chris · together at Principia Biopharma (2013–2019) →Peter
Ask Jamie Chen to introduce you to Peter
You →Jamie · 7 people · together at Chiron Corporation →Peter
Ask Sam Okafor to introduce you to Peter
You →Sam · 2 people · together at BD →Peter
Sign up to find every way you can get introduced to Peter
- Your email: the people you already email who know Peter
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Peter
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Peter Thompson is a General Partner at OrbiMed, which he joined in 2010, with over 25 years of industry experience. He previously held executive roles at Becton-Dickinson and Chiron, co-founded and served as CEO of Trubion Pharmaceuticals, co-founded several OrbiMed portfolio companies, and worked at the National Cancer Institute after internal medicine training at Yale. He holds a bachelor's degree in Molecular Biology and Mathematics and a medical degree from Brown University, and is a board-certified internist and oncologist.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Board director at Terremotobio
Intro paths
In turn, Peter can intro founders to Terremotobio's investors below.
Terremotobio's investors · 6
Board director at Alpheus Medical
Intro paths
In turn, Peter can intro founders to Alpheus Medical's investors below.
Board director at Janux Therapeutics
Intro paths
In turn, Peter can intro founders to Janux Therapeutics's investors below.
Janux Therapeutics's investors · 3
Experience
- Terremoto BiosciencesChairman, Co-Foundercurrent2024 — present
- Terremoto BiosciencesCEO, Co-Founder2021 — 2024
- OrbiMed AdvisorsGeneral Partnercurrent2022 — present
- OrbiMed AdvisorsPartner2013 — 2021San Francisco, New York
- OrbiMed AdvisorsVenture Partner2010 — 2013
- Silverback TherapeuticsCo-Founder, Chairmancurrent2016 — present
- Silverback TherapeuticsCo-Founder, Chairman, CEO2016 — 2020
- Edgewise TherapeuticsChairman, Co-Foundercurrent2017 — presentBoulder, CO
- Corvus PharmaceuticalsCo-Founder, Directorcurrent2014 — present
- Cleave BioSciencesCo-Founder, Directorcurrent2010 — present
- University of WashingtonAffiliate Professor, Neurosurgerycurrent2010 — present
- Principia BiopharmaChairman of the Board2013 — 2019
- Strategicon PartnersCEO, Managing Director2001 — 2013
- Trubion PharmaceuticalsCo-Founder, Chairman, CEO2002 — 2009
- ATP CapitalVenture Partner2002 — 2005
- Chiron CorporationVP, GM Chiron Informatics1995 — 1999
- BDVP, R&D1991 — 1995
- National Cancer InstituteLab Head1985 — 1992
Skills & more
+8 more
InvestmentsCommercializationScienceR&DBiopharmaceuticalsDue DiligenceStart-upsClinical DevelopmentFrom Peter's professional profile.
Deals · 1
Prevail TherapeuticsBoard seat
via OrbiMed · filed Mar 2018 · $65M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
AdaptimmuneAlpine Immune SciencesAnthera PharmaceuticalsAspen NeuroscienceCardioxyl PharmaceuticalsCarrot FertilityCleave TherapeuticsDecibel TherapeuticsEdgewise TherapeuticsJanux TherapeuticsOttimo PharmaPMV PharmaceuticalsPrincipia BiopharmaProlynxReCode TherapeuticsSierra OncologySionna TherapeuticsSynthorxTerremotobio
Sources: SEC Form D filings · curated public sources.
Colleagues at OrbiMed
Frequently asked questions
- Who is Peter Thompson?
- Peter Thompson is a General Partner at OrbiMed, which he joined in 2010, with over 25 years of industry experience. He previously held executive roles at Becton-Dickinson and Chiron, co-founded and served as CEO of Trubion Pharmaceuticals, co-founded several OrbiMed portfolio companies, and worked at the National Cancer Institute after internal medicine training at Yale. He holds a bachelor's degree in Molecular Biology and Mathematics and a medical degree from Brown University, and is a board-certified internist and oncologist.
- Where does Peter Thompson work?
- Peter Thompson is General Partner at OrbiMed and Board director at Terremotobio and Board director at Alpheus Medical and Board director at Janux Therapeutics.
- What does Peter Thompson invest in?
- Peter Thompson invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- What check size does Peter Thompson write?
- Peter Thompson typically writes checks of $1M – $75M.
- What boards does Peter Thompson sit on?
- Peter Thompson holds tracked board seats at Prevail Therapeutics.
- What companies has Peter Thompson invested in?
- Investments tracked here include Adaptimmune, Alpine Immune Sciences, Anthera Pharmaceuticals, Aspen Neuroscience, Cardioxyl Pharmaceuticals, Carrot Fertility, Cleave Therapeutics, Decibel Therapeutics, Edgewise Therapeutics, Janux Therapeutics, Ottimo Pharma, PMV Pharmaceuticals, and 7 more.
- Where did Peter Thompson go to school?
- Peter Thompson studied at Brown Medical School (M.D., medicine); Brown University (Bachelor's Degree, Molecular Biology, Mathematics).
Founder mafias
Brown University mafia321
Also came through, then founded or led a company.
BD mafia25
Also came through, then founded or led a company.
OrbiMed mafia14
Also came through, then founded or led a company.
Brown Medical School mafia7
Also came through, then founded or led a company.
Principia Biopharma mafia5
Also came through, then founded or led a company.
Same school
Also attended Brown Medical School8
+ 2 more
Also attended Brown University813
+ 807 more
Shared employers
Also worked at Silverback Therapeutics3
Also worked at Edgewise Therapeutics6
Also worked at University of Washington217
+ 211 more
Also worked at Principia Biopharma7
+ 1 more